Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes
- PMID: 28009779
- PMCID: PMC7228606
- DOI: 10.1097/TP.0000000000001620
Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes
Abstract
Background: Carbapenem-resistant Enterobacteriaceae (CRE) is an emergent microorganism of infections after liver transplant (LT). The aim of this study was to analyze the risk factors for CRE acquisition and infection after LT.
Methods: This was a prospective cohort study involving patients who underwent LT in the 2010 to 2014 period. Surveillance cultures for CRE were collected immediately before LT and weekly thereafter until hospital discharge.
Results: We analyzed 386 patients undergoing a total of 407 LTs. Before LT, 68 (17.6%) patients tested positive for CRE, 11 (16.2%) of those patients having CRE infection, whereas 119 (30.8%) patients acquired CRE after LT. Post-LT CRE infection was identified in 59 (15.7%) patients: Klebsiella pneumoniae was isolated in 83.2%; surgical site infection was the most common type of infection (46.7%). Multivariate analysis showed that post-LT dialysis was the only risk factor for post-LT CRE acquisition. Eighty-two percent of patients who underwent 3 or more post-LT dialysis sessions and acquired CRE before LT evolved with post-LT CRE infection. Other risk factors for CRE infection were acquisition of CRE post-LT, Model for End-Stage Liver Disease score greater than 32, combined transplantation, and reoperation. Patients who acquired CRE before LT had a high risk of developing CRE infection (P < 0.001).
Conclusions: Measures for minimizing that risk, including altering the antibiotic prophylaxis, should be investigated and implemented.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Surgical site infection after liver transplantation in the era of multidrug-resistant bacteria: what new risks should be considered?Diagn Microbiol Infect Dis. 2021 Jan;99(1):115220. doi: 10.1016/j.diagmicrobio.2020.115220. Epub 2020 Sep 22. Diagn Microbiol Infect Dis. 2021. PMID: 33045498
-
Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes.Liver Transpl. 2016 May;22(5):615-26. doi: 10.1002/lt.24389. Liver Transpl. 2016. PMID: 26684547
-
Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients.Liver Transpl. 2012 Apr;18(4):468-74. doi: 10.1002/lt.23374. Liver Transpl. 2012. PMID: 22467548
-
[Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients].Z Gastroenterol. 2015 Nov;53(11):1276-87. doi: 10.1055/s-0041-106855. Epub 2015 Nov 12. Z Gastroenterol. 2015. PMID: 26562402 Review. German.
-
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).Expert Rev Anti Infect Ther. 2016;14(1):95-108. doi: 10.1586/14787210.2016.1106940. Epub 2015 Nov 4. Expert Rev Anti Infect Ther. 2016. PMID: 26535959 Review.
Cited by
-
The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae.Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):755-765. doi: 10.1007/s10096-019-03468-4. Epub 2019 Jan 24. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30680569
-
Risk Factors and Outcomes of Carbapenem-Resistant Enterobacteriaceae Infection After Liver Transplantation: A Retrospective Study in a Chinese Population.Infect Drug Resist. 2020 Nov 10;13:4039-4045. doi: 10.2147/IDR.S278084. eCollection 2020. Infect Drug Resist. 2020. PMID: 33204121 Free PMC article.
-
Epidemiology, Susceptibility, and Risk Factors Associated with Mortality in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Abdominal Solid Organ Transplant Recipients: A Retrospective Cohort Study.Infect Dis Ther. 2021 Mar;10(1):559-573. doi: 10.1007/s40121-021-00411-z. Epub 2021 Feb 21. Infect Dis Ther. 2021. PMID: 33611687 Free PMC article.
-
Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.Ann Clin Microbiol Antimicrob. 2023 Jan 29;22(1):10. doi: 10.1186/s12941-023-00560-8. Ann Clin Microbiol Antimicrob. 2023. PMID: 36710337 Free PMC article.
-
Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.Antibiotics (Basel). 2022 Mar 15;11(3):387. doi: 10.3390/antibiotics11030387. Antibiotics (Basel). 2022. PMID: 35326850 Free PMC article.
References
-
- Zhong L, Men TY, Li H. Multidrug-resistant gram-negative bacterial infections after liver transplantation—spectrum and risk factors J Infect 2012. 64299–310 - PubMed
-
- Bodro M, Sabé N, Tubau F. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients Transplantation 2013. 96843–849 - PubMed
-
- Ye QF, Zhao J, Wan QQ. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality Transpl Infect Dis 2014. 16767–774 - PubMed
-
- van Duin D, van Delden C. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation Am J Transpl 2013. 1331–41 - PubMed
-
- Freire MP, Abdala E, Moura ML. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients Infection 2015. 43315–323 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical